Spotlight Growth
No Result
View All Result
Saturday, March 25, 2023
  • Home
  • News
    • Bio/Med/Pharma
    • Cannabis
    • Commodities
    • Consumer Goods
    • Crowdfunding
    • Cryptocurrency
    • Crypto Cheat Sheets
    • Earnings
    • Entertainment
    • Financials
    • Market News
    • Opinion
    • Politics
    • Technology
    • Venture Capital/Private Equity (VC/PE)
  • Video
  • Stock and Crypto Screener
  • Home
  • News
    • Bio/Med/Pharma
    • Cannabis
    • Commodities
    • Consumer Goods
    • Crowdfunding
    • Cryptocurrency
    • Crypto Cheat Sheets
    • Earnings
    • Entertainment
    • Financials
    • Market News
    • Opinion
    • Politics
    • Technology
    • Venture Capital/Private Equity (VC/PE)
  • Video
  • Stock and Crypto Screener
No Result
View All Result
No Result
View All Result
Home Cannabis

Hempacco (NASDAQ: HPCO) Reports Revenue for First Half of 2022 Reaches $2.8 Million, Up 486% Y/Y

by admin
October 12, 2022
in Cannabis
0
Hempacco NASDAQ HPCO Revenue 1H 2022 Spotlight Growth

Hempacco NASDAQ HPCO Revenue 1H 2022 Spotlight Growth

Hempacco Co., Inc. (NASDAQ: HPCO) is a manufacturer, distributor and marketer of hemp-based alternatives to traditional hemp-based cigarettes. The company also has hemp-based rolling papers and related accessories. Shares of the hemp smokables company are surging 42% through afternoon trading on Wednesday, October 12, 2022. Over the past three months, Hempacco has seen average daily volume of 2.4 million shares. However, volume of 24.7 million shares or dollar volume of around $76.57 million, has already exchanged hands through afternoon trading.

Shares of Hempacco are soaring after the company announced revenue results for the six month period ended June 30, 2022. The company reports total revenue for the first half of 2022 came in at $2.8 million, which represents year-over-year growth of 486%. Hempacco says the revenue growth has been driven by its long-term $9.2 million purchase order from HBI-Raw, one of the largest smoking paper companies in the world. The HBI-Raw deal initially launched during the fourth quarter of 2021, with continuous deliveries since the beginning of 2022.

Hempacco has also been working on building its other partnerships with Hemp Hop, Rick Ross & Rap Snacks founder James Lindsay, and a 50/50 partnership with Cheech and Chong.

Sandro Piancone, co-founder and CEO of Hempacco, says revenue growth really accelerated during the second quarter. Q2 2022 revenues surged 93% from Q1 2022 results, as gross operating margins increased from 18% to 25%. The company has continued to maintain strict cost controls and has reduced operating expenses by 45%, which helped drive a breakeven earnings-per-share result for Q2 this year.

Jorge Olson, Co-Founder and CMO of Hempacco, added, “Our growth in the first half of the year is even more impressive when you consider the capital we had available at the time. Now, with the proceeds raised in our Nasdaq IPO, we are operating from a significantly strengthened position which we believe will enable us to further accelerate sales growth moving forward.”

Disclosure: No position. Spotlight Growth has no relationships with any of the companies mentioned in this article and did not receive payment in any form for its creation. This is an opinion article and is not meant to be financial advise. We are not broker-dealers or investment professionals. Please conduct your own due diligence. For more information on our disclosures, please visit: https://spotlightgrowth.com/disclosures/

Tags: cannabiscommon stockday tradingdow jones todayemerging growthHBI-Rawhemphemp cbdhemp cigaretteshemp productshemp rolling papershemp stocksHempaccoHPCOHPCO stockinvestinginvesting newsinvestmentmanufacturingmarijuana stocksmedical cannabismedical marijuanamicrocap stocksNASDAQnewsnon nicotine cigarettespublic companyRaw rolling paperssalesservicessmall cap companiessmall cap stockssmall capsSpotlight GrowthSpotlight Growth Stocksstock marketstocksstocks to watchtobacco alternativestradingwebull wallstreetbets
  • Trending
  • Comments
  • Latest
Asure Software NASDAQ ASUR Human Capital Management HCM Industry Spotlight Growth

Asure Software (NASDAQ: ASUR) is Expanding to Meet the Rising Demand for Human Capital Management Software

September 27, 2022
OLB Group NASDAQ OLB Cuentas NASDAQ CUEN Partnership Fintech Spotlight Growth

OLB Group (NASDAQ: OLB) and Cuentas (NASDAQ: CUEN) Team Up to Bring Fintech Solutions to Over 32,000 Bodegas Across the United States

October 6, 2022
Siyata Mobile NASDAQ SYTA SYTAW SD7 VK7 Purchase Orders Spotlight Growth

New Purchase Orders for SD7 Rugged Device, VK7, and Other Accessories Boost Siyata Mobile’s Outlook (NASDAQ: SYTA)

December 14, 2021
Telcoin TEL Crypto Spotlight Growth

Telcoin (TEL) Quietly Leads a Crypto Remittance Revolution

June 15, 2021
Cybersecurity Stocks Coming Into Focus Amid High-Profile Attacks

Cybersecurity Stocks Coming Into Focus Amid High-Profile Attacks

0
Safe-T SFET NASDAQ UN Presentation

Safe-T (NASDAQ: SFET) Has Been Selected to Present at the United Nations’ Office of Information and Communications Technology Event

0
Safe-T Group SFET Q4 FY 2020 Financial Results

Safe-T Group (NASDAQ: SFET) Reports Fourth Quarter and Full Year 2020 Financial Results

0
Safe-T Group NASDAQ SFET FY 2020 Prelim

Safe-T Group Ltd. (NASDAQ: SFET) Estimates Record-High Annual Revenues of Approximately $4.9 Million Representing ~50% Growth YoY 2020

0
Is U.S. Government Trying to Ban Crypto Spotlight Growth

Is The U.S. Government Trying to Ban Crypto?

March 23, 2023
Bioadaptives OTC Pink BDPT LOI World Wellness Health and Wellness Spotlight Growth

Bioadaptives (OTC Pink: BDPT) Signs LOI with World Wellness, LLC to Develop New Health and Wellness Products

March 23, 2023
JanOne NASDAQ JAN Sells ARCA Recycling Business Focus on Biopharma Spotlight Growth

JanOne (NASDAQ: JAN) Sells ARCA Recycling Business to VM7, Will Focus on Budding Biopharmaceuticals Business

March 22, 2023
89bio NASDAQ ETNB Phase 2b ENLIVEN Trial Pegozafermin NASH Spotlight Growth

89bio (NASDAQ: ETNB) Reports Phase 2b ENLIVEN Trial of Pegozafermin Achieved Primary Endpoints For Treatment of Nonalcoholic Steatohepatitis (NASH)

March 22, 2023

Recent News

Is U.S. Government Trying to Ban Crypto Spotlight Growth

Is The U.S. Government Trying to Ban Crypto?

March 23, 2023
Bioadaptives OTC Pink BDPT LOI World Wellness Health and Wellness Spotlight Growth

Bioadaptives (OTC Pink: BDPT) Signs LOI with World Wellness, LLC to Develop New Health and Wellness Products

March 23, 2023

Categories

  • Bio/Med/Pharma
  • Cannabis
  • Commodities
  • Consumer Goods
  • Crowdfunding
  • Crypto Cheat Sheets
  • Cryptocurrency
  • Earnings
  • Education
  • Entertainment
  • Financials
  • Market News
  • Opinion
  • Politics
  • Real Estate
  • Split Watch
  • Sponsored
  • Store
  • Technology
  • Uncategorized
  • Venture Capital/Private Equity (VC/PE)

Site Navigation

  • Disclosures
  • Terms Of Service
  • Privacy Policy
  • Contact Us

Copyright © 2017-2022 Spotlight Growth. All Right Reserved. Designed by Cool Cat Interactive.

No Result
View All Result
  • Home
  • News
    • Bio/Med/Pharma
    • Cannabis
    • Commodities
    • Consumer Goods
    • Crowdfunding
    • Cryptocurrency
    • Crypto Cheat Sheets
    • Earnings
    • Entertainment
    • Financials
    • Market News
    • Opinion
    • Politics
    • Technology
    • Venture Capital/Private Equity (VC/PE)
  • Video
  • Stock and Crypto Screener

Copyright © 2017-2022 Spotlight Growth. All Right Reserved. Designed by Cool Cat Interactive.

Newsletter Signup

Subscribe to our weekly newsletter below and never miss the latest small/micro-cap analysis and investment news from Spotlight Growth.

Enter your email address

Thanks, I’m not interested